Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-01-11 @ 1:40 PM
Study NCT ID:
NCT00991458
Status:
COMPLETED
Last Update Posted:
2013-07-11
First Post:
2009-10-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Cyclosporine in Post-LASIK Patients
Sponsor:
Allergan
Organization:
Study Overview
Official Title:
Study of Cyclosporine in Post-LASIK Patients
Status:
COMPLETED
Status Verified Date:
2013-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and efficacy of Cyclosporine 0.005% and 0.010% eye drops administered twice daily before and following LASIK surgery.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: